Literature DB >> 263477

Content of chorionic gonadotropin in human fetal tissues.

I T Huhtaniemi, C C Korenbrot, R B Jaffe.   

Abstract

As part of a study on the physiological role of hCG in the human fetus, the hCG concentrations in homogenates of various fetal tissues were measured using a hCG beta subunit RIA. The mean concentrations (picograms of hCG per mg wet tissue +/- SEM; n greater than 10, unless otherwise indicated) found in human fetuses of 12-20 weeks were: ovary, 46.9 +/- 4.3; testis, 8.2 +/- 1.7; kidney, 20.3 +/- 2.8; thymus, 11.5 +/- 1.2; adrenal, 2.6 +/- 0.4; lung, 3.4 +/- 0.7; liver, 1.8 +/- 0.2; spleen, 1.4 +/- 0.4 (n = 5); muscle, 2.4 +/- 0.8 (n = 6); and meconium, 356 +/- 104. That the immunoreactive material measured behaved like hCG was determined by RIA of the supernatants. Parallelism was demonstrated between dilution curves for the tissue homogenates and the hCG standard for all tissues except meconium. A rat Leydig cell in vitro bioassay was used to demonstrate that there was hCG biological activity in the supernatants in ovarian, thymic, and renal tissues. The mean ratios of biological to immunological activities were 5.3 in kidney (n = 4), 1.6 in thymus (n = 3), and 1.3 in ovary (n = 2). Blood content of the tissues was determined from measurements of hemoglobin levels and it was found that for the ovary, testis, kidney, and thymus, hCG concentrations were higher than could be explained by the presence of circulating hCG in the tissues. These results, together with our previous results of the binding and effects of hCG in the human fetal testis, support the fact that the fetal testis is a target organ for hCG in the stimulation of steroidogenesis. The presence of high levels of hCG in the ovary, thymus, kidney, and meconium poses questions for further study of the possible physiological role of hCG.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263477     DOI: 10.1210/jcem-46-6-994

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Expression of type II chorionic gonadotropin genes supports a role in the male reproductive system.

Authors:  Andrew M Parrott; Ganapathy Sriram; Yijun Liu; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

2.  Fetal tissue can synthesize a placental hormone. Evidence for chorionic gonadotropin beta-subunit synthesis by human fetal kidney.

Authors:  W G McGregor; W J Raymoure; R W Kuhn; R B Jaffe
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

3.  Fetal sex differences in human chorionic gonadotropin fluctuate by maternal race, age, weight and by gestational age.

Authors:  J J Adibi; M K Lee; S Saha; W J Boscardin; A Apfel; R J Currier
Journal:  J Dev Orig Health Dis       Date:  2015-08-05       Impact factor: 2.401

4.  A toolkit for the application of placental-fetal molecular biomarkers in epidemiologic studies of the fetal origins of chronic disease.

Authors:  Jennifer J Adibi; Alexander J Layden; Qing Yin; Xiaoshuang Xun; Shyamal Peddada; Rahel L Birru
Journal:  Curr Epidemiol Rep       Date:  2020-12-28

5.  The postnatal presence of human chorionic gonadotropin in preterm infants and its potential inverse association with retinopathy of prematurity.

Authors:  Tammy Z Movsas; Nigel Paneth; Ira H Gewolb; Qing Lu; Gregory Cavey; Arivalagan Muthusamy
Journal:  Pediatr Res       Date:  2019-09-19       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.